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Abstract: The Fusarium mycotoxin enniatin B (ENN B) is a so-called emerging mycotoxin frequently
contaminating poultry feed. To investigate the impact of chronic ENN B exposure on animal health,
broiler chickens were fed either a diet naturally contaminated with ENN B (2352 µg/kg) or a control
diet (135 µg/kg) for 2, 7, 14, or 21 days. ENN B concentrations were determined in plasma and
liver using a validated ultra-high performance liquid chromatography—tandem mass spectrometry
UHPLC-MS/MS method. Liver was evaluated histologically, and the villus length and crypt depth
of the duodenum, jejunum, and ileum were measured. Histopathology of the livers did not reveal
major abnormalities. Feeding an ENN B-contaminated diet could possibly inhibit the proliferation of
enterocytes in the duodenal crypts, but did not affect villus length, crypt depth, or villus length-crypt
depth ratio of the jejunum and ileum. ENN B levels in plasma and liver were significantly higher
in the ENN B-fed group and ranged between <25–264 pg/mL and <0.05–0.85 ng/g, respectively.
ENN B carry-over rates from feed to liver tissue were 0.005–0.014% and 0.034–0.109% in the ENN B
and control group, respectively. Carry-over rates were low and indicated a limited contribution of
poultry tissue-derived products to the total dietary ENN B intake for humans. The above results
support the opinion of the European Food Safety Authority stating that adverse health effects from
ENN B in broiler chickens are unlikely.
Keywords: Enniatin B; broiler chicken; chronic dietary intake; carry-over; liver residue;
intestinal toxicity
Key Contribution: Chronic dietary intake of the Fusarium mycotoxin enniatin B in broiler chickens
has a low impact on the intestinal morphometry. Above, histopathological examination of the liver
did not reveal abnormalities and carry-over of enniatin B from feed into the liver was limited.
1. Introduction
Enniatins (ENNs) are mycotoxins produced by a variety of Fusarium fungi, contaminating
mainly grain and grain-based products. As reviewed by Fraeyman et al. (2017), enniatin A (ENN A),
enniatin A1 (ENN A1), enniatin B (ENN B), and enniatin B1 (ENN B1) are the ENNs most frequently
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detected in feed, with a maximum prevalence ranging between 87% and 95%. Maximum contamination
levels reported in feed were 1745, 2216, 1514, and 1846 µg/kg for ENN A, ENN A1, ENN B and ENN B1,
respectively [1]. In a recent Danish study, ENN B was the most prevalent ENN, with all of the analyzed
cereal samples (n = 110) being contaminated, and this was found in the highest concentration with a
maximum contamination level of 3900 µg ENN B/kg in rye. In this study it was not specified whether
the cereals were intended for human or animal consumption [2].
In vitro studies showed that ENN B is cytotoxic in different cell types, such as human
adenocarcinoma colon (Caco-2) and human colon carcinoma (HT-29) cells, presumably due to its
ionophoric properties. Moreover, in vitro studies suggest effects on endocrinology and immunity.
In human adrenocortical carcinoma cells (H295R) ENN B reduced progesterone, testosterone,
and cortisol secretion, and modulated the expression of genes involved in steroidogenesis. ENN B
increased IL-10 secretion, interfered with dendritic cell migration, and decreased endocytosis by
macrophages in vitro [1,3–7]. However, in vivo studies on the effects of dietary ENN B in livestock
and companion animal are limited to poultry [1,7,8]. Feeding a multi-mycotoxin-contaminated diet
including ENN A (28 µg/kg), ENN A1 (491 or 440 µg/kg), ENN B (12,716 or 11,233 µg/kg), ENN B1
(4057 or 3599 µg/kg), and beauvericin (BEA; 10,313 or 8926 µg/kg), for 14 days to broiler chickens or
laying hens did not influence growth, feed intake and egg production [9].
Since the toxicokinetic properties of a mycotoxin determine the systemic exposure,
such toxicokinetic studies are essential to evaluate the risks of dietary ENNs for human and animal
health. Fraeyman et al. (2016) demonstrated that ENN B is poorly absorbed in broiler chickens after
oral administration, with an absolute oral bioavailability of merely 11%. Furthermore, the total body
clearance was high, namely 7.10 L/h/kg and 7.18 L/h/kg after intravenous injection (iv) and oral
administration (po), respectively [10]. Although a low oral bioavailability was observed, it was also
demonstrated that ENN B was readily distributed, since a volume of distribution of 33.9 and 29.4 L/kg
was noted after iv and po administration, respectively. This can possibly lead to residues in edible
tissues, such as liver. Due to the low oral bioavailability and the rapid clearance, systemic adverse
health effects of dietary ENN B are unlikely in poultry [10]. This was also acknowledged by the
European Food Safety Authority (EFSA), who identified no-observed-adverse-effect levels (NOAELs)
of 763 and 674 µg ENN B/kg body weight per day for broiler chickens and laying hens, respectively [3].
On the other hand, both relatively high dietary exposure and the low oral absorption may lead
to relatively high intestinal ENN B concentrations in broiler chickens, possibly leading to toxicity
and impaired intestinal health. Previously, an influence on the intestinal mucus layer and epithelial
antioxidative response in broiler chickens has been demonstrated for other Fusarium mycotoxins such
as deoxynivalenol and fumonisins [11]. However, to the authors’ knowledge, no in vivo intestinal
toxicity studies have been described before for the emerging ENN B. In vitro, ENN B induced cytotoxic
effects in different intestinal cell lines. Low levels of ENN B (1.5–3 µM or 960–1920 µg/L) resulted in
the generation of reactive oxygens species, lipid peroxidation, cell cycle arrest, apoptosis, and necrosis
in Caco-2 cells, and reduction of transepithelial electrical resistance in intestinal porcine epithelial cells
of the jejunum (IPEC-J2) [7,12].
Therefore, the aim of present study was to investigate the impact of feeding
an ENN B-contaminated diet on the intestines and liver of broiler chickens, using morphometric
and histological examinations, respectively. Moreover, an ultra-high performance liquid
chromatography—tandem mass spectrometry (UHPLC-MS/MS) method was developed and
validated to quantify ENN B in liver tissue, in order to calculate the transfer of ENN B from feed to
liver tissue.
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2. Results
2.1. Method Validation for Liver Tissue Analysis
The UHPLC-MS/MS method for the quantification of ENN B in liver was highly sensitive, with a
limit of quantitation (LOQ) and detection (LOD) of 0.05 ng/g and 0.001 ng/g, respectively. A good
linearity was observed, since the correlation coefficient was >0.9986 and the goodness-of-fit coefficient
was 4.45%. There was no carry-over, since no peak higher than the LOD was detected at the elution
zone of ENN B or the internal standard (IS) after injection of the reconstitution solvent. The results of
the evaluation of the accuracy and precision fell within the acceptance criteria, and are summarized in
the Supplementary Materials (Table S1).
2.2. Feeding Trial
Feeding the ENN B-contaminated diet did not significantly affect body weight gain (p = 0.556,
Figure 1), measured as the difference in body weight at the start of the experiment and at the age of
euthanasia, over the age range studied. The average daily ENN B exposure in the ENN B-fed group was
396, 679, 312, and 316 µg ENN B/kg body weight/day at the age of 2, 7, 14, and 21 days, respectively.
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ENN B fed group (Table 1, p = 0.016). However, only a limited number of duodenal slides were 
available, which could bias the statistics, and therefore the statistically significant difference was 
probably not biologically relevant. 
ENN B concentrations in plasma (Figure 2) and liver (Figure 3) were significantly higher in the 
ENN B-fed group compared to the control in both plasma (p = 0.023) and liver (p = 0.003). ENN B 
levels ranged between <25–94 pg/mL and <25–264 pg/mL in plasma of broiler chickens fed the control 
and the ENN B-contaminated diet, respectively. ENN B levels in liver ranged between <0.05–0.29 and 
0.05–0.85 ng/g in the control and ENN B group, respectively. Analysis of variance (ANOVA) showed 
no interaction between feed and age, thus the effect of the feed on the plasma concentration, liver 
concentration, villus length, crypt depth, and villus length-crypt depth ratio was independent of the 
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Figure 1. Body weight gain of broiler chickens fed the Enniatin B (ENN B)-contaminated diet and the
control diet for 2, 7, 14, and 21 days. No significant differences in weight gain were observed between
both diets (n = 8 in each group).
Histopa ological xamination of the live did not r veal bnormalities nor major differences
between the ENN B-fed group and the control group (Supplementary Figure S1). Regarding intestinal
toxicity, feeding the ENN B-contaminated diet did not significantly affect villus length, crypt depth or
villus length-crypt depth ratio, except for crypt depth of the duodenum, which was smaller in the ENN
B fed group (Table 1, p = 0.016). However, only a limited number of duodenal slides were available,
which could bias the statistics, and therefore the statistically significant difference was probably not
biologically relevant.
ENN B concentrations in plas a (Figure 2) and liver (Figure 3) were significantly higher in the
ENN B-fed group comp red to the control in both plasma (p = 0.023) and liver (p = 0.0 3). ENN B levels
ranged between <25–94 pg/mL and <25–264 pg/mL in plasma of broiler hickens fed the control
and the ENN B-contaminated diet, respectively. ENN B levels in liver ranged between <0.05–0.29
and 0.05–0.85 ng/g in the control and ENN B group, respectively. Analysis of variance (ANOVA)
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showed no interaction between feed and age, thus the effect of the feed on the plasma concentration,
liver concentration, villus length, crypt depth, and villus length-crypt depth ratio was independent of
the age.
Table 1. Villus length, crypt depth and villus length-crypt depth ratio of the duodenum, jejunum
and ileum of broilers after feeding a control or an ENN B-contaminated diet for 2, 7, 14, or 21 days.
The mean of five measurements per segment per animal was calculated. Results are presented as the
mean of eight animals per group ± standard deviation.
Duodenum
Age (Days)
Villus Length (µm) Crypt Depth (µm) 3 Villus Length/Crypt Depth
ENN B Control ENN B Control ENN B Control
2 761 ± 207.9 976 ± 169.5 83 ± 15.0 109 ± 34.7 9 ± 2.3 12 ± 0.9
7 1283 ± 169.6 1303 ± 87.6 105 ± 32.6 137 ± 21.8 13 ± 4.6 10 ± 0.8
14 - 1 1526 ± 193.4 - 1 158 ± 6.7 - 1 10 ± 1.6
21 2109 ± 491.8 1780 2 133 ± 7.5 158 2 14 ± 1.2 11 2
Jejunum
Age (Days)
Villus Length (µm) Crypt Depth (µm) Villus Length/Crypt Depth
ENN B Control ENN B Control ENN B Control
2 376 ± 34.6 389 ± 65.2 83 ± 11.2 87 ± 10.7 5 ± 0.6 5 ± 0.6
7 518 ± 225.8 561 ± 114.7 92 ± 13.3 122 ± 21.7 6 ± 0.6 4 ± 1.9
14 951 2 932 ± 217.0 132 2 142 ± 62.6 7 2 7 ± 0.8
21 868 ± 232.6 887 ± 171.8 128 ± 17.6 134 ± 32.7 7 ± 2.4 7 ± 1.6
Ileum
Age (Days)
Villus Length (µm) Crypt Depth (µm) Villus Length/Crypt Depth
ENN B Control ENN B Control ENN B Control
2 322 ± 40.2 301 ± 56.9 80 ± 7.5 71 ± 15.6 4 ± 0.4 4 ± 0.8
7 509 ± 177.2 488 ± 81.1 105 ± 35.8 116 ± 15.2 5 ± 2.5 4 ± 0.3
14 613 ± 213.9 466 ± 123.2 123 ± 28.4 116 ± 43.6 4 ± 0.6 4 ± 0.9
21 598 ± 180.9 685 ± 133.1 165 ± 24.3 150 ± 32.2 4 ± 1.1 5 ± 1.3
1 Due to technical problems during preparation of the histological slides, data are unavailable; 2 or only a single
measurement was possible; 3 Over the age ranges studied, no significant differences were found between the control
diet and the ENN B diet (p range = 0.054–0.984), except for crypt depth of the duodenum (p = 0.016).
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Figure 3. Mean (+SD) ENN B concentration in livers of broiler chickens fed the ENN B contaminated
diet and the control diet f r 2, 7, 14 and 21 days (n ran between 7–8 animals per group).
The ENN B carry-over from feed into liver ranged between 0.005–0.014% in the ENN B fed group
and betwee 0.034–0.109% in the control group. Regarding carry-over, ANOVA showed an interaction
between feed and age. Although still low, carry-over rate was significantly higher in the control group
at the age of 7 and 14 days compared to the ENN B group (p < 0.01). Mean carry-over rates ± standard
deviation were 0.014 ± 0.011 and 0.109 ± 0.030 at the age of 7 days for ENN B and the control group,
respectively. At 14 days of age, mean carry-over rates ± standard deviation were 0.007 ± 0.006 and
0.091 ± 0.058% for the ENN B and control group, respectively.
3. Discussion
To the best of our knowl dge, the effect of chronic dietary ENN intake on intestin l and hepatic
health of broiler chicken has not b en thor ughly investi ated b fore. Microscopic examination of
the liver did not reveal major histopathological abnormalities. This is in accordance with the EFSA
opinion since the highest mean daily ENN B exposure of 679 µg ENN B/kg body weight/day at the
age of 7 days was still below the NOAEL of 763 µg ENN B/kg body weight/day [3]. The average
daily ENN B exposure in the ENN B fed group was remarkably higher at the age of 7 days (679 µg
ENN B/kg body weight/day), compared to the other age groups studied (312–396 µg ENN B/kg
body weight/day). This explains the tendency of a higher ENN B liver concentration at 7 days of age,
and this is related to the hig r feed intake/kg body weight in younger a imals, in c nformity to the
Ross 308 Broiler Performance Objectives [13]. To our knowle ge, no ot er in vivo studies investigating
hepatotoxic effects of ENN B have been published. A multi-parametric liver toxicity test using the
human hepatocellular carcinoma cell line Hep-G2 demonstrated an acute hepatotoxic response from
0.9 µM ENN B (576 µg/L) onward [2]. O the other hand, an IC50 valu could not be calculated
in Hep-G2 cells using the methylthiazoltetrazolium salt (MTT) assay at concentrations up to 30 µM
(19,194 µg/L) [6]. These concentrations are a factor of 700 and 22,600 higher compared to the highest
concentration found in the liver of the broiler chickens in the present study, respectively.
Accordingly, dietary ENN B did not significantly alter villus length, crypt depth or villus
length-crypt depth ratio of the jejunum and ileum. Statistics showed a smaller crypt depth in the
duodenum of the ENN B fed group, suggesting an inhibitory effect of ENN B on the proliferation
of duodenal enterocytes. However, the number of histological slides examined was limited, and the
difference is potentially not biologically relevant.
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Although the contamination level of the feed was relatively high (2353 µg/kg), and despite
the high volume of distribution of ENN B in broiler chickens (Vd up to 34 L/kg) [10], the ENN B
concentrations found in plasma (up to 264 pg/mL) and liver (up to 0.85 ng/g) were low. This is
in accordance with the low absolute oral bioavailability (F = 11%), the high total body clearance
(Cl = 7 L/h/kg), and the biotransformation of ENN B in broiler chickens [10]. It should be mentioned
that no extrapolation to other ENNs or other animal species can be made. As an example, a high oral
bioavailability (F = 91%) for ENN B1 in pigs has been reported [14].
Callebaut et al. fed a multi-mycotoxin-contaminated diet to broilers and laying hens in order to
determine residue levels in meat, liver, skin, and eggs [9]. Dietary contamination levels were 1710 or
2228 µg deoxynivalenol/kg, 488 or 606 µg HT-2 toxin/kg, 367 or 343 µg T2 toxin/kg, 753 or 820 µg
zearalenone/kg, 41 or 66 µg 3-acetyldeoxynivalenol/kg, 91 or 227 µg 15-acetyldeoxynivalenol/kg,
28 µg ENN A/kg, 491 or 440 µg ENN A1/kg, 12,716 or 11,233 µg ENN B/kg, 4057 or 3599 µg
ENN B1/kg, and 10,313 or 8926 µg BEA/kg in feed for broiler chickens or laying hens, respectively.
Feeding the multi-mycotoxin-contaminated diet did not affect growth, feed uptake, nor egg production.
Carry-over rates in liver were 0.16%, 0.12%, and 1.57% for ENN B, ENN B1, and BEA, respectively.
In the present study, mean carry-over rates from feed to liver ranged between 0.005–0.014% in the
ENN B-fed group, and 0.034–0.109% in the control group. Although still low, the carry-over rates
were significantly higher for the control diet compared to the ENN B diet at the age of 7 and 14 days.
Mean carry-over rates were 0.014% (ENN B) and 0.109% (control) at the age of 7 days, and 0.007%
(ENN B) and 0.091% (control) at the age of 14 days. The higher carry-over rate in the control group
could possibly indicate a saturation of absorption. However, this is in contrast with the study of
Callebaut et al. who found a higher carry-over rate (0.16%) after feeding a more heavily contaminated
diet. Furthermore, Callebaut et al. detected traces of ENN A and ENN A1 in meat, while traces of
α-zearalenol were detected in both skin and liver. However, no other toxins than ENN B, ENN B1 and
BEA could be quantified in these tissues. Highest mean concentrations reported by Callebaut et al.
were 20.5 µg/kg (ENN B), 3.8 µg/kg (ENN B1), and 162 µg/kg (BEA) in liver, and 50 µg/kg (ENN B),
15 µg/kg (ENN B1), and 120 µg/kg (BEA) in skin. Carry-over rates in skin were 0.39% (ENN B),
0.37% (ENN B1) and 1.16% (BEA). In contrast, carry-over rates in meat were lower and ranged between
0.04–0.01% (ENN B), 0.041–0.025% (ENN B1), and 0.026–0.03% (BEA) [9]. In a Finnish survey, ENN B
was found in turkey meat samples (up to 2 µg/kg) and in one out of 24 broiler liver sample (<0.4 µg/kg)
collected from slaughterhouses. Mycotoxin concentrations in feed were not determined in this study.
Therefore, it was not possible to determine the carry-over rates [15]. ENN B concentrations were not
determined in meat samples in the present study. The concentrations reported in the liver samples in
the present study are in line with those reported in the Finnish survey [15]. Although the carry-over
rates of ENN B in liver vary, they are relatively low [9]. Besides, Finnish eggs (56–79%) and egg yolks
(99.7%) were frequently contaminated with BEA and/or ENNs, but contamination levels were usually
low. Maximum concentrations were higher in egg yolks compared to whole eggs and were 1.3 µg/kg,
7.5 µg/kg, 3.8 µg/kg, 7.0 µg/kg and 1.3 µg/kg for ENN A, ENN A1, ENN B, ENN B1 and BEA,
respectively [16]. As determined by Callebaut et al., carry-over rates in eggs were 0.10%, 0.05% and
0.44% for ENN B, ENN B1 and BEA, respectively. Furthermore, Callebaut et al. quantified ENN B in a
number of Belgian pig liver samples. However, no concentration or prevalence was reported. Thus no
conclusions can be drawn regarding carry-over into pig-derived tissues [9].
Taken together, our data complement the EFSA opinion and suggest a low intestinal and systemic
toxicity of ENN B in broiler chickens. The data on carry-over and residues of ENNs are limited,
but nevertheless suggest a low contribution of ENNs from poultry-derived products to the total dietary
ENN intake for humans. Since no extrapolation to other animal species can be made, future studies
should focus on the toxicity, toxicokinetics and residues of ENNs and BEA in livestock animals other
than poultry.
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4. Materials and Methods
4.1. Chemicals, Products and Reagents
Analytical standard of ENN B was purchased from Fermentek (Jerusalem, Israel). The internal
standard (IS) [15N3]-ENN B was synthesized according to Hu and Rychlik (2012) [17]. ENN B
and the IS were stored at ≤−15 ◦C. Glacial acetic acid, water, methanol, and acetonitrile were
of LC-MS grade (Biosolve, Valkenswaard, The Netherlands). Aceton was purchased from VWR
(Leuven, Belgium). Millex-GN nylon filters (0.20 µm) were purchased from Merck-Millipore
(Merck-Millipore, Overijse, Belgium).
4.2. Stock and Working Solutions
Stock solutions of ENN B (100 µg/mL) and the IS (10 µg/mL) for analytical experiments were
prepared in methanol and stored at −20 ◦C. Working solutions of ENN B (ranging from 0.5–50 ng/mL)
were prepared by appropriate dilution of the stock solutions in acetonitrile. These working solutions
were used for the preparation of matrix-matched calibration standards and quality control samples
and were freshly prepared for each analytical batch.
4.3. Experimental Diets
The feed was a custom-made wheat/rye (43%/7.5%) based mash diet, with soybean meal as the
main protein source. Feed samples (500 g) were taken at three different locations in each batch, pooled,
and analyzed with a validated LC-MS/MS method to quantitate aflatoxin B1, B2, G1 and G2, altenuene,
alternariol, alternariol methylether, deoxynivalenol, 3-acetyldeoxynivalenol, 15-acetyldeoxynivalenol,
diacetoxyscirpenol, ENN B, fumonisins B1, B2 and B3, fusarenon-X, neosolaniol, nivalenol, ochratoxin
A, roquefortine-C, sterigmatocystin, T-2 toxin, HT-2 toxin, and zearalenone [18]. The decision limit
(CCα) of each mycotoxin is summarized in the Supplementary Table S2 and was defined as the
concentration at “the y intercept plus 2.33 times the standard deviation of the within laboratory
reproducibility” (α = 1%), in the case of mycotoxins for which no maximum permitted limit has been
established or only a maximum guidance level in feed has been recommended [19]. In the case of
aflatoxin B1, CCα was established by spiking blank feed around the European maximum permitted
limit of 0.02 mg/kg feed [20]. The corresponding concentration at the permitted limit plus 1.64 times
the standard deviation of the within laboratory reproducibility equals the decision limit (α = 5%) [18].
The experimental ENN B diet was naturally contaminated with 2352 µg/kg ENN B and 160 µg/kg
nivalenol, while the control diet was naturally contaminated with 135 µg/kg ENN B, 87 µg/kg
nivalenol and 223 µg/kg deoxynivalenol. All other mycotoxins were below the corresponding CCα.
4.4. Feeding Trial
Sixty-four 1-day-old broiler chickens (Ross 308) of mixed gender were obtained from a commercial
hatchery (Vervaeke-Belavi, Tielt, Belgium) and were randomly divided into two equal experimental
groups. Each experimental group was housed in a different pen of 1.5 m2 with wood shavings.
The environmental temperature was adjusted to the changing needs of the animals according to their
age and an 18/6-h light/darkness program was applied. The animals had ad libitum access to drinking
water and feed. Chickens were fed the ENN B contaminated diet or the control diet from day 1 until day
21. All animals were weighed at day 1, 2, 7, 14, and 21 and the feed intake per group was recorded daily.
Using the mean body weight, feed intake and feed contamination level, the mean ENN B exposure per
kg body weight was calculated for each age category. Eight animals of each group were euthanized
on day 2, 7, 14, and 21 by intravenous injection of sodium pentobarbital (Natrium Pentobarbital
20%, Kela Veterinaria, Sint-Niklaas, Belgium) 3 h after the beginning of the light/darkness cycle.
The total weight gain was defined as the difference in body weight between the start and the end of
the experiment for each age category. The liver of each animal was collected to determine the effects of
the diet using histology examinations. Accordingly, a sample of the duodenum, jejunum, and ileum
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of each animal was collected for morphometry. The samples were fixed in neutral-buffered formalin
immediately after euthanasia, and were embedded in paraffin and stained with hematoxylin and eosin,
using standard procedures. Liver was histologically evaluated by an independent pathologist. Due to
technical problems, the number of histological slides of the duodenum was limited and was five or
three, four, zero or two, and two or one for the ENN B or control group at the age of 2, 7, 14, and 21 days,
respectively. Villus length and crypt depth of the duodenum, jejunum, and ileum were measured using
a light microscope with Leica LAS software (Leica Microsystems, Diegem, Belgium). To determine
ENN B concentrations in biological samples, blood and liver tissue samples were collected immediately
after euthanasia. Blood samples were collected in heparinized tubes and centrifuged (2851× g, 10 min,
4 ◦C) and an aliquot of 250 µL plasma was stored at ≤−15 ◦C. Carry-over rate (%) was defined as the
ratio of the ENN B concentration in the liver and the concentration in feed, multiplied by 100.
The animal experiment was approved by the Ethical Committee of the Faculties of Veterinary
Medicine and Bioscience Engineering of Ghent University (EC 2013/170) on the ninth of January 2014.
4.5. Quantification of ENN B in Plasma and Liver
ENN B plasma concentrations were measured using a validated UHPLC-MS/MS method as
described by Fraeyman et al. (2016) [10]. The LOD and LOQ for ENN B in plasma were 0.091 pg/mL
and 25 pg/mL, respectively. In short, sample preparation consisted of deproteinization of plasma
(250 µL) with acetonitrile (750 µL), followed by centrifugation (8517× g, 10 min, 4 ◦C). The acetonitrile
phase was evaporated under a gentle nitrogen stream and the dry residue was reconstituted in 250 µL
of acetonitrile/water (80/20, v/v). For liver tissue, 25 µL of a 25 ng/mL IS working solution was added
to 1.0 g homogenized liver. Liver samples were extracted with 2 × 5 mL of acetone using a rotary
mixer (Trayster digital, IKA®, Staufen, Germany, 70 rpm, 10 min) and centrifuged (2851× g, 10 min).
The aceton phases were collected and evaporated under a nitrogen stream and the dry residue was
reconstituted in 250 µL of methanol/water (90/10, v/v). After a vortex-mixing step, the sample was
filtered through a Millex-GN nylon filter and transferred to an autosampler vial. A 5 µL aliquot was
injected onto the UHPLC-MS/MS instrument.
The UHPLC-MS/MS system consisted of an Acquity H-Class UPLC coupled to a Xevo TQ-S
mass spectrometer (Waters, Zellik, Belgium). The column used was a 50 mm × 2.1 mm i.d., 1.7 µm,
C18 Acquity UPLC BEH column, with a 5 mm × 2.1 mm i.d. VanGuard BEH C18 guard column of the
same material (Waters, Zellik, Belgium). Mobile phase A consisted of 0.1% glacial acetic acid in water,
whereas mobile phase B consisted of acetonitrile. The following gradient elution program was run:
0.0–0.5 min (50% B), 0.5–6.0 min (linear gradient to 85% B), 6.0–8.0 min (85% B), 8.0–8.1 min (linear
gradient to 50% B), 8.1–10.0 min (50% B). The flow rate was set at 300 µL/min. The column oven and
tray temperature were set at 45 ◦C and 7 ◦C, respectively. The LC column effluent was interfaced to a
Xevo TQ-S mass spectrometer (Waters, Zellik, Belgium) equipped with an electrospray ionization (ESI)
probe operating in the positive ionization mode. Acquisition was performed in the multiple reaction
monitoring (MRM) mode. Product ions with the highest signal intensity were used as quantitation
ion. The following transitions (m/z) were monitored for qualification and quantitation, respectively,
for ENN B: 640.4 > 214.2 and 640.4 > 196.2, and for IS: 643.3 > 215.3 and 643.3 > 197.1. Cone voltage
and collision energy was set at 20.0 eV and 80.0 V, respectively.
4.6. Method Validation for Liver Tissue
The developed method was in-house validated based on the protocol described by
De Baere et al. (2011) [21], using spiked blank liver samples obtained from healthy, untreated broiler
chickens. Linearity, accuracy, precision, limit of quantitation (LOQ), limit of detection (LOD) and
carry-over were determined in compliance with the recommendations and guidelines defined by the
European Community and with criteria described in the literature [21–25].
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4.6.1. Calibration Curves
Matrix-matched calibration curves (range 0.05–5 ng/g) were prepared in 1.0 g of blank broiler
chicken liver. The correlation coefficients (r) and goodness-of-fit coefficients (gof) were calculated and
limits were set at ≥0.99 and ≤20%, respectively [21,24,25], with gof:
gof =
√
∑(% difference)2
n− 1 with % difference =
xback calculated − xnominal
xnominal
× 100 (1)
4.6.2. Accuracy and Precision
Within-run accuracy and precision (repeatability) were determined by analyzing six blank samples
that were spiked at 0.05, 0.5 and 5 ng/g in the same run. The between-run accuracy and precision
(reproducibility) were determined by analyzing two blank samples spiked at 0.05, 0.5, and 5 ng/g
on three different days (n = 6). The acceptance criteria for accuracy were: −50% to +20% and −30%
to +10% for concentration levels ≤1 ng/g, and between 1 and 10 ng/g, respectively. The precision
was evaluated by the determination of the relative standard deviation (RSD), which had to be below
the RSDmax value. For the within-day precision, RSDmax is fixed at 30% and 25% for concentrations
≤1 ng/g and between 1 and 10 ng/g, respectively [23]. For between-run precision, the RSD had to be
below the RSDmax value calculated by the Horwitz equation [23]. These RSDmax values were 71.0%,
50.2%, and 35.5% for concentrations at 0.05 ng/g, 0.5 ng/g, and 5 ng/g, respectively.
4.6.3. Limit of Quantitation and Limit of Detection
The LOQ was the lowest concentration of the analyte for which the method was validated with
an accuracy and precision that fell within the recommended ranges. Samples with a concentration
below the LOQ were considered negative. The LOQ was also established as the lowest point of the
calibration curve and was determined by analyzing six samples spiked at a concentration level of
0.05 ng/g, on the same day. The LOD was defined as the lowest concentration that could be recognized
by the detector with a signal-to-noise (S/N) ratio of ≥3. The LOD values were calculated using the
mean S/N of the blank samples spiked at the LOQ level.
4.6.4. Carry-Over
Absence of carry-over was verified by analyzing the reconstitution solvent injected after the
highest calibration sample (5 ng/g). If a peak was observed in the elution zone of ENN B or the IS,
it had to be below the LOD.
4.7. Statistical Analysis
A two factor ANOVA was performed on weight gain, feed intake, plasma concentration,
liver concentration, carry-over from feed to liver, villus length, crypt depth, and villus length-crypt
depth ratio of the duodenum, jejunum, and ileum samples, using SPSS Statistics 23. Fixed factors
were feed (ENN B and control) and age (2, 7, 14, and 21 days). The Levene’s test showed equality of
error variances for all parameters, except for villus length of the jejunum, villus length of the ileum
and crypt depth of the jejunum. Equality of error variances could be assumed when the logarithm of
these parameters was calculated. Two factor ANOVA showed no interaction between feed and age,
except for carry-over from feed to liver. The level of significance was set at 0.05.
Supplementary Materials: The following are available online at www.mdpi.com/2072-6651/10/1/45/s1,
Table S1: Results of the Within- and Between-run Precision and Accuracy Evaluation for the Analysis of ENN B
in Broiler Chicken Liver; Table S2: Decision Limit (CCα) of the Mycotoxins analyzed in the Experimental Diets;
Figure S1: Histology of the liver of broiler chickens (20×).
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